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Conflict and Vaccine-Preventable Disease in Children under Five in the
Eastern Mediterranean Region: A Systematic Review
Background: Conflict is one of the main reasons for our failure to reach worldwide
immunization targets. An objective of 90% immunization coverage is included in the fourth
Millennium Development Goal to reduce under-five mortality by two thirds, which is still far
from achieved in the conflict-ridden Eastern Mediterranean Region (EMR). Despite global
progress, vaccine-preventable deaths still account for 20% of childhood mortality under five
years of age in the EMR, and communicable disease a third of all mortality. Conflict remains a
critical root cause of low vaccination coverage in the EMR, resulting in high levels of vaccinepreventable disease, disability, and death.
Research Question: The aim of this review is to assess the impact of conflict on vaccinepreventable disease vaccination coverage and outcomes in children under five in the Eastern
Mediterranean Region. While international attention is drawn to outbreaks of polio and measles,
several other easily avoidable infections are also responsible for high rates of morbidity and
mortality, especially in children. This review will give a more holistic view on the burden of
vaccine-preventable disease associated with conflict, as well as identify gaps in our current
knowledge and explore common factors in prevention of immunization uptake.
Methods: This systematic review was performed using the PRISMA guidelines. Search terms
related to conflict, the EMR, vaccines in the WHO Expanded Programme for Immunization
(EPI) package, and children were entered into MEDLINE, Embase, Global Health, and
Cochrane. Eighty seven unique articles were identified, and after an abstract and full text review
and a forward search, 26 were retained for data extraction and analysis.
Results: Results were distributed between four different countries of origin (Afghanistan,
Pakistan, Somalia, and Sudan), five different countries of study (Afghanistan, Pakistan, Sudan,
Somalia, and Kenya), and six out of ten diseases in the EPI (poliovirus, measles, hepatitis B,
tetanus, diphtheria, and pertussis). The majority of results addressed poliovirus (n=16) and
measles (n=9). Outcomes, vaccination coverage, and barriers to vaccination was analyzed
according to disease.
Conclusions: There is a large gap of knowledge regarding vaccine-preventable diseases in
children under five in conflict-affected areas of the Eastern Mediterranean Region.
Understanding the prevalence, mortality, and barriers to vaccination involved in these
challenging environments will help us reach the WHO goals of 90% vaccination coverage and
reduce worldwide childhood mortality.
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Introduction
Conflict and infectious disease come hand in hand, as we are recently reminded by outbreaks of
polio, measles, typhoid, and hepatitis A in the growing Syrian refugee camps. Three years of
civil conflict has led to the death of 125,000 and the displacement of over 2.7 million (UNHCR
2014). Polio has reemerged after 14 years of elimination due to the breakdown of health systems
and lack of sanitation, and 80% of excess deaths can be attributed to communicable disease.
Unfortunately, many these deaths were easily preventable – immunization coverage was as low
as 60% across Syria in 2012, leaving the population increasingly vulnerable to outbreaks (Coutts
& Fouad, 2014). This situation is not uncommon in the Eastern Mediterranean Region (EMR).
In the 20th century, between 191 and 231 million people died as a direct or indirect result
of conflict, with civilian greatly outnumbering combatant deaths (Otterson et al., 2014). In 2013
alone, the UNHCR estimated 38.7 million people of concern throughout the world, including
refugees and internally displaced people
Table 1. Countries in the Eastern Mediterranean Region
(UNHCR, 2013).
(EMR), as defined by the World Health Organization
The EMR is particularly conflictAfghanistan
Kuwait
Saudi Arabia
ridden, beyond Syria’s ongoing conflict
Bahrain
Lebanon
Somalia
(see Table 1). Since 1975, 18 out of 21
Dijbouti
Libya
Sudan
Egypt
Morocco
Syrian Arab Republic
countries in the region have experienced
Iran
Oman
Tunisia
some sort of organized conflict (Uppsala,
Iraq
Pakistan
United Arab Emirates*
2013). Conflict-related mortality
Jordan*
Qatar*
Yemen
increasingly shifts towards the civilian
*has not experienced a conflict since 1975 (Uppsala, 2013)
population, and civilian death accounts for
st
90% of conflict-related mortality in the 21 century (Okonko et al., 2009). Specifically in the
EMR, hundreds of thousands of civilian deaths are estimated in the last decade in Afghanistan,
Iraq, and Syria alone, and 10.8 million refugees and IDPs have resulted from conflicts solely in
Afghanistan, Pakistan, Sudan, and Syria (Otterson et al., 2014; UNHCR, 2013). Mortality is
highest among children under five years of age largely due to the disruption of normal childhood
health services, resulting in high rates of diarrheal diseases, acute respiratory infections, measles,
malaria, and severe malnutrition, followed by outbreaks of other communicable diseases such as
pertussis and meningococcal meningitis (Zwi, 2006; Toole & Waldman, 1997). A large portion
of these deaths are easily preventable with vaccination. Causes of death have not changed
significantly since the change of the century, emphasizing the necessity of increasing uptake of
vaccination in conflict-affected areas (Moss et al., 2006).
The implications of conflict reach beyond violence-related death and disability to the
destruction of infrastructure, food shortages, and the mass displacement of people, creating an
ideal environment for the spread of infectious disease (Toole & Waldman, 1997). In recent
conflicts in Iraq and Syria, healthcare services have been directly targeted, forcing physicians to
flee and hospitals to be deserted (Otterson et al., 2014). These conflicts disrupt the delivery of
essential interventions such as vaccinations, in addition to making populations more vulnerable
to infectious diseases and interrupting surveillance and response programs (Okonko et al., 2009).
Vaccination is a highly cost effective intervention, as available care post-infection is limited,
with an estimated total of $162 per capita spent on healthcare in the EMR, compared to the
global average of $845 in 2009, and even less in conflict-areas of the EMR (Haq et al., 2013). In
these low-income settings, vaccination is an essential, cost-effective intervention needed to
prevent excess mortality.
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Conflict and vaccine-preventable disease
Conflict is known to be one of the main reasons for our failure to reach worldwide immunization
targets (Haq et al., 2013). An objective of 90% immunization coverage is included in the fourth
Millennium Development Goal, to reduce under-five mortality by two thirds, which is still far
from achieved in the conflict-ridden EMR.
Vaccination efforts in the EMR began in 1974 with the founding of the Expanded
Programme on Immunization (EPI) by the WHO. EPI was created to expand access to
vaccination to children and women in developing countries, at a time when less than 5% of
children worldwide were receiving vaccinations in the first year of life. At the time, the
“traditional” package included four vaccinations (BCG, DPT, OPV, and measles) for six
diseases: tuberculosis, diphtheria, pertussis, tetanus, poliomyelitis, and measles (UNICEF, 2011).
The EPI was progressively adopted by all countries, and was universal by the early 1980s
(Mansoor, 2008).
By 2013, global coverage of these four vaccinations reached 83%, and the EPI vaccination
package now includes eight vaccinations targeting a total of ten diseases (listed in Table 2)
(UNICEF, 2011). Yellow fever vaccine was added to the package in 1988 for affected countries
in Africa and South America; yellow fever is recommended for Sudan and Somalia, so it was
included in this systematic review (Gershman & Staples, 2013). Hepatitis B vaccine was added
in 1992 for high burden countries and expanded to all countries by 1997. Haemophilus
influenzae type B (Hib) was added to the list for high burden countries in 1998 and extended to
all countries by 2006. Possible vaccinations being considered as future additions to the EPI
package may include pneumococcal conjugate vaccine (PCV), rotavirus vaccine, human
papillomavirus vaccine (HPV), and regionally specific vaccines including typhoid, Japanese
encephalitis, and meningitis (Mansoor, 2008).
The EPI has since developed the Global Vaccine Action Plan (GVAP), which aims to
eliminate polio and prevent 24-26 million deaths through the expanded vaccination package by
2020 (WHO 2013, GVAP, 2013). One of the elements of GVAP’s Strategy is to research the
best delivery approaches for humanitarian emergencies, fragile states, and countries in or
emerging from conflict (GVAP, 2013).
Despite this global progress, vaccine-preventable deaths still account for 20% of childhood
mortality under five years of age in the EMR (WHO-EM, 2011), and communicable disease a
third of all mortality in the region (Haq et al., 2013). Weak health systems, insufficient
government financial allocations, low community awareness and trust of services, regional
instability, and lack of coordination between humanitarian and health care workers hinders the
effective delivery of health services such as
Table 2. Vaccine-preventable diseases included in the
vaccination (Haq et al., 2013; Okonko et al.,
Expanded Programme for Immunization (EPI)
2009). Conflict remains a critical root cause
Diphtheria
Poliomyelitis
of low vaccination coverage in the EMR,
Hepatitis
B
Rubella
resulting in high levels of vaccineHaemophilus Influenzae type B Tetanus
preventable disease, disability, and death.
Measles
Tuberculosis
Prevention and response

Pertussis (whooping cough)

Yellow Fever

Prevention of these vaccine-preventable diseases is difficult to navigate in conflict settings.
Adequate food, shelter, water, sanitation and immunization are difficult to achieve in war-
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affected countries. Early warning systems, surveillance, and emergency preparedness planning
are critical to establish before situations become unmanageable, with a foundation of standard
public health policies, treatment protocols, staff training, and the maintenance of reserves of
essential drugs and vaccines for use in emergencies (Toole, 1997). Rapid assessments are often
overlooked, when the early identification of the most vulnerable sub-populations could save
many lives. Initially channeling resources towards addressing measles, diarrheal disease,
malnutrition, and acute respiratory infections among women and children is know to be a cost
effective approach to preventing excess mortality. Immunizing children between 6 months and 5
years of age is known to be the single most important and cost-effective intervention in
emergency-affected populations, which should then be followed by the other vaccines in the EPI
package (Haq et al., 2013).
The current guidelines for prevention of vaccine-preventable disease in the Sphere Project
Minimum Standards in Humanitarian Response call for an immediate estimation of measles
vaccination coverage in children aged 9 months to 15 years to prevent future outbreaks. If
vaccination coverage is below 90%, a vaccination campaign should be launched for children
aged 6 months to 15 years, including Vitamin A administration, and coverage should be
maintained above 95% for any mobile or displaced populations as newcomers come to the camp.
Measles vaccination should then be followed with the rest of the EPI package as soon as the
situation has somewhat stabilized (Sphere Handbook, 2011).
Research questions
The aim of this systematic review is to assess the impact of conflict on vaccine-preventable
disease outcomes in the Eastern Mediterranean Region. While international attention is drawn to
outbreaks of polio and measles, a long list of other easily avoidable infections is responsible for
high rates of morbidity and mortality, especially in children. This review will give a more
holistic view on the burden of vaccine-preventable disease associated with conflict, as well as
identify gaps in our current knowledge and explore common factors in prevention of
immunization uptake. Until these factors are better understood and addressed, achievement of the
MDGs will continue to fall short.
Methods
Literature was reviewed based on the preferred reporting items for systematic review and metaanalysis (PRISMA) guidelines.
Search strategy for identification of studies
Searches were conducted in the databases MEDLINE, Embase, Global Health, and Cochrane
Library, and all searches were limited to the English language and from 1974 (the year that EPI
was established) to the February 2014 search date. Search criteria included a combination of one
or more conflict-related terms, one or more vaccine-preventable disease-related terms, and all
countries included in the WHO-defined Eastern Mediterranean Region. It should be noted that
the EMR differs from the World Bank-defined Middle East and North Africa (MENA) Region
by a few countries (EMR does not contain MENA countries Algeria, Israel, Malta or West Bank
& Gaza, but does contain Afghanistan, Pakistan, Somalia, and Sudan) (WHO, 2014; World
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Bank, 2013). Conflict-related keywords included “refugees,” “internally displaced,” “displaced
persons,” “conflict affected,” “post conflict,” “war,” and “terrorism.” Search terms for vaccinepreventable diseases included “diphtheria,” “hepatitis B,” “haemophilus influenza type B”,
“measles,” “whooping cough,” “poliomyelitis,” “rubella,” “tetanus,” and “pertussis.” Childrelated terms included “child” and “infant.” See appendix Table A1 for the full search strategy.
Search terms related to conflict were based on those used in systematic reviews by Jack et
al. (2013) and Roberts & Browne (2010). Child-related search terms were based on those used in
the systematic review about child mental health in conflict by Jordans et al (2009). Vaccinepreventable disease terms were taken from the included vaccines in the EPI package (Mansoor,
2008). Countries included in the search terms included all of those in the World Health
Organization list of countries in the Eastern Mediterranean Region (WHO, 2014).
Study selection
When screening the search results, articles that did not address populations within the Eastern
Mediterranean Region and one of the pre-specified vaccine-preventable diseases were omitted.
In addition, editorials and commentaries were excluded. Studies addressing refugees who were
relocated to high-income countries were excluded due to their differing circumstances compared
to those still living in low- and middle-income countries. Beyond these initial criteria, articles
were evaluated by comparing them to the main components of our study question:
1.
2.

Is the article specifically focused on children under five in a conflict-affected
population?
Is the article examining risk factors or outcomes of mortality, incidence, and/or
prevalence of vaccine-preventable diseases?

The database searches yielded 87 unique results after removing duplicates (see Figure 1 for
selection process). The abstracts of this initial sample were screened by a single reviewer,
resulting in the exclusion of 39 articles. The most common reasons for exclusion included a
focus on refugees relocated a high-income country (n= 17) or an editorial or commentary (n=10).
Forty-eight articles were retained for full text review. Articles were excluded if they were a
commentary, editorial, or letter to the editor, did not include an outcome relevant to the study
question, a conflict-related term did not appear in the full text, the population didn’t include
children under five, or the full text was not available.
At the conclusion of full text screening, a total of 16 articles were retained for data
extraction and analysis. A forward search was performed on the references of these 16 articles,
and 61 articles were identified to be of potential interest to the research question based off of
their titles. After screening these 61 articles, 10 were added to the final sample, 14 were
identified as grey literature, and 37 were excluded based on the criteria used in the full text
screening. The grey literature was not included in final data extraction and analysis.

Adams 6
Figure 1.
Systematic Literature Review Process
!

Electronic Database Search
(n= 87 unique articles after removing duplicates)
Gross number of articles identified in each database:
MEDLINE: 52
Global Health: 31
Embase: 58
Cochrane Library: 0

Abstract Review
(n= 87)

Articles excluded based on abstract review
(n= 39)
Reasons for exclusion:
• Focus on refugees relocated to high-income countries (n= 17)
• Editorial or commentary (n= 10)
• Study population did not originate within EMR (n= 4)
• Not about vaccine-preventable diseases (n= 3)
• Unrelated (n= 3)
• Pre-1974 (n=1)
• Evaluation of vaccine efficacy (n=1)

Full Text Screening
(n= 48)
Articles excluded based on full text review
(n= 32)
Reasons for exclusion:
• Editorial, commentary, or letter to editor (n= 10)
• Population did not include children <5 years (n= 5)
• Did not include outcome relevant to study question (n= 5)
• Poster presentation or conference abstract (n= 4)
• Age group for children was not specified <5 years (n=4)
• Conflict-related term not mentioned in full text (n= 2)
• No full text available (n= 1)
• Policy recommendations (n= 1)
Retained for Analysis
(n= 16)
Forward Search
(n= 61 unique articles of interest identified from references)

Final Sample
(n= 26)

Identified:
• Articles to be included in analysis (n= 10)
• Grey literature (n= 14; not included in final analysis)
Reasons for exclusion:
• Conflict-related term not mentioned (n= 11)
• Did not include outcome relevant to study question (n= 7)
• No full text available (n= 7)
• Not EMR-specific (n= 5)
• Population did not include children <5 years (n= 3)
• Editorial, commentary, or letter to editor (n= 2)
• Low quality (n= 2)
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Results
A total of 26 articles were retained in the final sample. Of these, 17 studies were Morbidity and
Mortality Weekly Reports (MMWRs) or Weekly Epidemiological Records (WERs) from the
CDC. Despite the inclusion criteria of studies published since 1974, publication years ranged
only from 1987 to 2014, with an average year of 2005. A full list of results and some basic
characteristics are included in the appendix in Table A2.
Types of Participants
Studies were included in the final sample if the participants were five years of age or younger
and were living in or recently displaced from a country in the Eastern Mediterranean Region.
Studies that defined children as <15 or <10, with no further breakdown to <5, were excluded.
Participants originating within the EMR and relocated to a low or middle income country were
included, but participants relocated to a high income country were excluded. Only one article
(Polonsky, 2013) addressed populations that originated within the EMR and relocated outside to
another low income country, Kenya. Studies were not included unless they mentioned conflict,
but the Uppsala Conflict Database was also used to cross-verify that the countries of participant’s
origin and/or study were conflict affected.
Location
Studies took place in Afghanistan, Pakistan, Somalia, Sudan, and Kenya. The participants’
countries of origin included Afghanistan, Pakistan, Somalia, and Sudan. Populations studied
Kenya originated in Somalia. Several studies in Pakistan also studied populations originating in
Afghanistan. The majority of articles focused on populations originating in either Afghanistan or
Pakistan. See Table 2 to see the full list of countries of origin and countries of study for the
articles included in the final sample.
Table 2. Results by Country of Origin and Study
Origin Study

Afghanistan
Bahrain
Dijbouti
Egypt
Iran
Iraq
Jordan

16
-

14
-

Origin Study

Kuwait
Lebanon
Libya
Morocco
Oman
Pakistan
Qatar

13
-

15
-

Origin Study

Saudi Arabia
Somalia
Sudan
Syrian Arab Republic
Tunisia
United Arab Emirates
Yemen
Kenya*

5
2
-

4
3
1

*Note: Kenya is not in the EMR, but the population studied originated from Somalia, a country in the EMR, so it
was included in this study.
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Vaccine-preventable diseases
Table 3. Results by Vaccine-Preventable Disease
Out of the 10 vaccinepreventable diseases included in
Diphtheria
1
Poliomyelitis
16
the EPI and included in this
Hepatitis B
1
Rubella
systematic review, only 6 were
Haemophilus Influenzae type B Tetanus
2
addressed in the final sample of
Measles
9
Tuberculosis
Pertussis (whooping cough)
1
Yellow Fever
articles. The majority of studies
focused on poliomyelitis or
measles, while only a few results addressed hepatitis B, tetanus, diphtheria, and whooping cough.
Four EPI-included diseases were not found in the results, including Haemophilus influenza type
B, rubella, tuberculosis, and yellow fever. A full list of results by vaccine-preventable disease is
contained in Table 3. See Table 4 for a matrix of results comparing vaccine-preventable disease
to population’s country of origin.
Table 4. Matrix of Results Comparing Country of Origin to Vaccine-Preventable Disease
Diphtheria
Afghanistan

Hepatitis B

Measles

1

3

Pertussis

Pakistan
Somalia
Sudan

Poliovirus

Tetanus

12

1

13
1

5
1

1

1
1

Poliomyelitis
Sixteen results addressed poliomyelitis in countries of the EMR. Of these 16 results, only one
was not a CDC MMWR or WER report. In addition, while each of these results was unique, five
pairs of reports presented the same annual data for cases and vaccination coverage for
Afghanistan and Pakistan.!
Only one result did not include Afghanistan and/or Pakistan, instead focusing on polio in
Sudan (MMWR, 2001). One result also gave an EMR-wide update (MMWR, 2000). Several of
the worldwide CDC updates did include numbers for other countries in the EMR (such as Egypt
and Sudan) but focused primarily on Afghanistan and Pakistan (MMWR, 2008; MMWR, 2009;
MMWR, 2010). Poliovirus remained endemic only in Afghanistan, Pakistan, and Nigeria by
2012, explaining the lack of results for other countries in the EMR. Poliovirus-specific results are
documented in the appendix Table A3, with extraction of the number of cases and immunization
coverage for each article in the final sample.
The number of confirmed WPV cases widely fluctuates in Afghanistan and Pakistan since
the first result in 1997 (see Figure 2). Poliovirus is not considered endemic in Sudan, and
transmission has been interrupted since 2009 (GPEI, 2010). No WPV3 cases have been reported
in Afghanistan since April 2010, and WPV3 persists in small numbers in Pakistan (MMWR,
2013). WPV2 was eliminated in 1999. In 1999, six countries reported indigenous strains of
poliovirus: Afghanistan, Egypt, Iraq, Pakistan, Sudan, and Somalia (CDC MMWR, 1999). In the
most recent report, only Afghanistan and Pakistan still had reportable cases (CDC MMWR,
2013), although the recent Syrian refugee outbreak will likely increase incidence in other EMR
countries as well.
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Figure 2. Wild poliovirus cases in the EMR,
as reported by CDC MMWRs

Year

Vaccination coverage increased from the least to most recent articles included in both
Afghanistan and Pakistan. Vaccination coverage was defined as three doses of oral polio vaccine
(OPV) in children less than one year old. In Afghanistan, the earliest article reported less than
30% OPV coverage in 1996 (CDC WER, 1999), whereas the latest article reported coverage of
66% in 2011 (CDC MMWR, 2013). This coverage fluctuated, reaching as high as 85% coverage
in 2009 (see Figure 3 for reported OPV coverage in Afghanistan and Pakistan) (CDC MMWR,
2010). Pakistan typically reported higher vaccination coverage than Afghanistan, but these data
were not reliable until recently and were most likely gross overestimations, especially when
considering the limited AFP surveillance data available (CDC MMWR, 2009). In addition,
Sudan reported routine OPV coverage of 90%, with some regional variation (CDC MMWR,
2001).

% Coverage OPV3 (National)

Figure 3. Oral Poliovirus Vaccine Coverage (3 Doses)
in Afghanistan and Pakistan, according to CDC MMWR Reports
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Regional differences in coverage were large in both countries. Provinces along the insecure
common border had the lowest immunization coverage throughout the years. In 2009, a range of
5 to >20% of children under five years in certain regions were inaccessible for vaccination due to
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security issues in Afghanistan, and a range of 10 to 30% of children in Pakistan (CDC MMWR,
2010). In Afghanistan in 2010, 84% of cases came from the conflict-affected south region, and
69% of cases in Pakistan came from conflict-affected Federally Administered Tribal Areas
(FATA) and Kyber-Pakhtoonkhwa Province (CDC MMWR, 2011). Every article in the
poliovirus sample subgroup described wide regional variation within the affected countries,
based on conflict and logistical access issues.
Supplementary immunization activities (SIAs) were common interventions used in
Afghanistan, Pakistan, Sudan, as well as other non-endemic countries to reach high-risk endemic
areas and migrant populations, trying to reach chronically missed children (CDC MMWR,
2012). National immunization days (NIDs) were also a common SIA referred to in every article,
which were mass campaigns that occurred over a short period of time, administering two OPV
doses to children under five years (CDC MMWR, 2001). SIAs totaled 26 in Pakistan and 18 in
Afghanistan in 2008 (CDC MMWR, 2009), 23 in Pakistan and 13 in Afghanistan in 2009 (CDC
MMWR, 2010), and 20 in Pakistan and 12 in Afghanistan in 2010 (CDC MMWR, 2010).
Commonly cited barriers to vaccination coverage included active conflict, insecurity and
weak managerial and operational coordination (CDC MMWR, 2013; CDC WER, 1999; CDC
MMWR, 2008; CDC MMWR, 2009; CDC MMWR, 2010; CDC MMWR, 2011). Increased
resources and political commitment were repeatedly called for (CDC MMWR, 2009; CDC
MMWR, 2011; CDC MMWR, 2012). Surveillance was weak or completely lacking for acute
flaccid paralysis (AFP) cases. Attacks on polio workers in December 2012 and early 2013 also
stalled SIA activities in Pakistan until increased security precautions were taken for workers.
However, accompaniment of polio workers by law enforcement has not had a positive influence
on increasing community vaccine acceptance or reducing parent refusal (CDC MMWR, 2013).
Measles
Nine articles addressed measles in the EMR, including five in Somalia, three in Afghanistan, and
one in Sudan. Most of these articles studied measles mortality on a refugee camp level. Mortality
for children under five years of age was disproportionately high in all of these camps, and every
study noted that measles, along with acute respiratory infections and diarrhea, was one of the
main causes of death. Percentage of death attributed to measles ranged from 8% in Afghan
refugee camps in 1984 (Boss, 1987) to over 60% in refugee camps in Somalia in the early 1980s
(Toole, 1988). Vaccination coverage also was reported as very low in every study, with the
highest coverage at 83.9% in Somali refugee camps in Kenya in 2011 after a vaccination
campaign following an outbreak (Polonsky, 2013), whereas countrywide vaccination coverage
within Somalia was reported as only 46% in 2010 and 2011. This two year interruption in
vaccination coverage resulted in a massive measles outbreak, with cases increasing from 145 to
1562 cases per million children under five years (Kebede, 2012). The need for persistent, high
coverage of vaccination was also demonstrated in the study in Kenya, where the breakdown in
registration and vaccination services resulted in a measles outbreak, spiking measles to account
for 17% of under five mortality (Polonsky, 2013). In addition, several studies showed high
resident mortalities from measles in addition to displaced and refugee populations (Moore, 1993;
Gessner, 1993), demonstrating the negative effects of conflict and infectious disease not only on
refugees and displaced people, but also residents of the countries.
Reasons for low coverage of measles vaccination included widespread fighting and
insecurity, remote location of communities, stock-outs, rainy seasons, and mass population
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movement (Boss, 1987; Toole, 1988; Assefa, 2001; CDC WER, 2004; Mirza, 2012). Many
articles stated entire regions were inaccessible for vaccination due to conflict, such as the
southern and central regions in Somalia in 2010 and 2011 (CDC MMWR, 2012) and western
Darfur in Sudan in 2004 (CDC WER, 2004). A few articles recommended strengthening of
community health programs to improve vaccination coverage, vitamin A delivery, and
malnutrition (Moore, 1993; Assefa, 2001). Child Health Days in Somalia proved to be an
effective approach, closing the gap between rural and urban populations and reaching 84% more
infants than prior traditional EPI approaches (Mirza 2012). Outbreak response immunization
(ORI) strategies were also implemented on a large scale in Kenya and Sudan. However, measles
cases persisted after the ORI campaigns, emphasizing the need for thorough prevention over
rapid response (CDC WER, 2004; Kebede, 2012). Several articles also called for improved
surveillance in conflict settings in order to determine the most effective approaches and
technologies for prevention and follow-up (Gessner, 1993; Toole, 1988; CDC WER, 2004).
Tetanus, Diphtheria, and Pertussis
Two articles addressed tetanus (Boss, et al., 1987; Mirza et al., 2012) and one additionally
addressed diphtheria and pertussis (Mirza, et al., 2012). While improvements in child mortality
were observed from 1984 to 1985 among Afghan refugees in Pakistan with a decrease from
22.5% to 18.8% of children dying before their fifth birthday, neonatal tetanus increased in
percentage of cause of death from 6 to 9%. However, differences were not statistically
significant. The EPI’s goal by 1990 was less than one death from neonatal tetanus per 1000 live
births, while this camp still had a level of 17 tetanus deaths per 1000 births (Boss et al., 2012).
The other study examined Somalia and its efforts with its child survival intervention of
Child Health Days within an unstable country with poor infrastructure. Child Health Days were
conducted every six months and were found to be successful in reducing urban and rural
disparities as well as increasing third dose of DPT coverage from 31% in 2008, to 51% in 2009,
to 66% in 2010. Security constraints in some regions proved to be the greatest obstacles to
increased coverage, but CHDs overall provided increased coverage compared to the usual efforts
of routine EPI services in Somalia’s fragmented healthcare system (Mirza, et al., 2012).
Other vaccine-preventable diseases
Only one result was found for hepatitis B, concerning Afghan refugees in Pakistan (Quddus,
2006). Seroprevalence in children under five was 5.9% (95% CI: 2.4 – 11.9%; Quddus, 2006)
compared to 2.4% prevalence in the general Pakistani pediatric population (Ali et al., 2009). In
addition, HBsAg positive mothers were 7.15 times more likely to have HBsAg positive children.
Hepatitis B vaccination was not included in the Balochistan camps at the time of the study, and
the article highly recommended its inclusion as a routine immunization (Quddus, 2006).
No results were found studying Hib, rubella, tuberculosis, or yellow fever in children under
five in conflict-affected EMR countries. Hib vaccine was only universally introduced into the
EPI package by 2006, which may explain the lack of results, and yellow fever is only
recommended in Somalia and Sudan (CDC, 2013). Tuberculosis typically affects older
populations, explaining the lack of results for children under five years old.
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Discussion
Countries and conflict timelines
Afghanistan has been in a constant state of conflict since 1978, involving intrastate conflict with
foreign involvement. Severe civil war, the Taliban movement, and US-led international
intervention characterized the constant state of upheaval and insecurity (Uppsala, 2013). This
history heavily influences Afghanistan’s weak health system and inability to eradicate polio.
Also, extensive foreign involvement may explain the large number of results based in
Afghanistan.
Pakistan has also experienced multiple interstate and intrastate conflicts since 1975.
Pakistan has engaged in clashes with India, was involved in the War on Terror against al-Qaida,
and has experienced many military coups and struggles over government power (Uppsala, 2013).
Provincially localized conflicts have heavily influenced vaccination coverage and disease
outbreaks, resulting in the high percentage of inaccessible populations reported in the CDC
MMWRs.
Sudan also is characterized by constant conflict. Especially noteworthy was South Sudan’s
fight for independence, which was won in 2011, followed by continued struggles over the
establishment of the border. The Sudan People’s Liberation Movement/Army struggled with the
government from 1983 to 2004, along with fighting in Darfur in 2003. Sudanese militias are
infamous for human rights violations and large scale one-sided violence (Uppsala, 2013). Again,
this persistent conflict through the decades explains historically low vaccination coverage, mass
displacement of people, and outbreaks of disease.
Somalia’s armed conflict has been continuous since the early 1980s, when opposition
groups attempted to overthrow President Barre. After his ousting in 1991, international troops
became involved until 1995 and Somalia went through two decades of dysfunctional governance
while also suffering from drought and famine (Uppsala, 2013). Mass displacements of people,
lack of governance, pervasive conflict, and a fragmented health system in which 80% of Somalis
lacked basic care have precipitated the crisis of high mortality from vaccine-preventable disease
(Mirza, 2012).
Strategies for moving forward
Strategic interventions are needed to reach these inaccessible children for vaccination and
prevent excess mortality associated with conflict. As shown throughout this systematic review,
prevention of these diseases becomes extremely difficult in insecure settings, despite the
effectiveness and cost-benefit of vaccination. Prevention can happen on many levels: primary
prevention equates to conflict resolution and stopping the violence; secondary prevention
involves contingency planning, surveillance, and personnel training; tertiary prevention means
the prevention of excess mortality through mass vaccination campaigns and humanitarian relief
(Toole & Waldman, 1997). Some recommendations for each level of prevention surfaced
throughout many of the articles in this review.
Interruption of poliovirus faces barriers posed by a disastrous mix of armed conflict, high
population density, poor sanitation, low of vaccination coverage, and weak or absent health
infrastructure (CDC MMWR, 2000). The Global Polio Eradication Initiative (GPEI) enacted a
strategic plan in 2010 in order to stop transmission of wild poliovirus by 2012. This plan focuses
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on targeted and planned approaches to address heterogeneity in OPV coverage and transmission
(WHO GPEI, 2012). In 2011, GPEI stated that the world is not on track for its end of 2012
global goal of ending all WPV transmission, or for any time soon after, without tackling
fundamental problems of security, managerial, and resource issues (CDC MMWR, 2012).
Pakistan was identified as the greatest overall risk to the GPEI in its 2011 meeting (CDC
MMWR, 2011).
Emergency plans were constructed for Afghanistan and Pakistan. SIAs need to involve
local leaders in planning and social mobilization, in order to focus on hard-to-reach areas, tailor
improved training, and target house-to-house canvassing. In addition, improved accountability is
needed in administrative leaders to improve supervision, monitoring, and performance of
vaccination teams (CDC MMWR, 2012). Technical support and human resources are needed in
polio-endemic countries in order to develop national capacity and expertise (CDC MMWR,
2013). Better planning, coordination, and surveillance are critical to quash further polio
transmission, and would operate on both the secondary and tertiary levels of prevention.
This mobilization of political commitment and resources could also help strengthen other
immunization and preventive services, as demonstrated in other countries (CDC WER, 1999).
Reaching high risk populations would help maintain a >95% measles vaccination coverage and
ensure herd immunity, as well as disseminate other critical vaccines in the EPI package. Capacity
for surveillance would grow, and awareness and utilization of routine services would increase.
Better management and local stakeholder involvement would not only improve OPV
implementation, but also build other basic health services.
“Days of tranquility” were also recommended in several of the articles of this search to
help reach high risk areas in prolonged conflict and little central governance (CDC MMWR,
2012; CDC MMWR, 2010). In order to execute this cease-fire intervention, negotiations with
community and conflict leaders needs to be enhanced. These days of tranquility will help reach
districts in Afghanistan and Pakistan with persistent polio transmission, as well as vaccinate
chronically missed children for measles in Sudan and Somalia. This strategy was used effectively
in El Salvador, lasting through the conflict from 1985 to 1992 and allowing 300,000 children to
be immunized annually, incidence of measles and tetanus to drop dramatically, and polio to be
eliminated (Krug, et al., 2002).
Vaccine diplomacy is another strategy that hints at primary prevention. As defined by
Novotny and Adams, global health diplomacy is “a political change activity that meets the dual
goals of improving global health while maintaining and strengthening international relations
abroad, particularly in conflict areas and resource-poor environments” (2007). Vaccine
diplomacy offers a potential opening for not only scientific collaboration but also an avenue of
foreign policy negotiations. The strategy dates back to the Cold War, in which US and Soviet
doctors partnered to develop the oral polio vaccine and improve the smallpox vaccine, leading to
eventual worldwide eradication. This model could be applied to diseases included in this
systematic review or other neglected tropical diseases, fostering collaboration and cooperation
while also serving the interests of both actors. Political, structural, and social peace building
would be fostered as public- and private- sector leaders negotiate opportunities for public health
interventions (Katz et al., 2011). Joint scientific collaboration with countries in the EMR could
lead to better international health and improved global security, as well as serve the health of the
society and the economy of these countries (Hotez, 2010).
More strategic interventions are needed to effectively increase basic vaccination coverage
and reduce excessive mortality in children under five associated with conflict in the EMR.
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However, as evidenced in this review, the key element must be total political commitment and
collaboration.
Limitations
The nature of this systematic review introduced several elements of bias. Publication bias must
be acknowledged, as many countries with fewer academic institutions or less foreign
involvement would have fewer papers published. Only four out of 18 conflict-affected countries
in the EMR had articles that fit the study criteria, and those four each have significant
humanitarian and foreign involvement. In addition, publication dates averaged to 2005, despite a
wide inclusion window from 1974 to present. This was partially influenced by increasing
publication rates in more recent years, as well as recent pushes to increase vaccination coverage
by GVAP, UNICEF, GPEI, the MDGs, and others. The international pressure for polio
eradication may explain its high proportion of articles (n= 17). In addition, universal coverage of
some of the EPI vaccines was only reached recently, perhaps explaining the lack of results for
Hib, tuberculosis, rubella, and yellow fever.
The results also cannot be considered perfectly reliable. Many numbers used in the
MMWRs are state reported, and other data are collected in challenging, insecure environments.
Many cases are missed due to the retrospective nature of the household surveys, based on recall
bias and dependent on the presence of at least one adult per household, and cause of death is
often misclassified due to the inexact nature of the interviews and assignment of symptoms.
While these studies are often the only way to estimate the current situation, they do not offer a
perfect assessment.
An important limitation to note is the restriction of this systematic review to published
literature. Grey literature of interest was identified in the forward search but not included in
analysis, only for relevant information in background and discussion. In addition, only articles in
English were included in this review, potentially missing many articles published from within the
EMR.
Finally, only a single reviewer screened the abstracts and full texts. In the future, a second
reviewer is needed to help reduce selection bias of articles and ensure that criteria are as
rigorously adhered to as possible.
Future directions
This systematic review clearly demonstrates a large gap in the literature concerning EPI
vaccination coverage and need in the EMR. Many conflict-affected countries are not represented
in this sample. Further research must be done to understand the impact of vaccine-preventable
diseases in conflict-affected areas and the interventions that would be most effective in each
context.
Beyond the EMR, this exercise would also be useful in conflict-affected countries around
the world. Vaccination delivery mechanisms across different countries and contexts would also
be interesting to examine. Cross-regional learning could help countries roll out vaccination
interventions in times of insecurity more effectively.
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Conclusions
Conflict remains one of the greatest threats to public health, resulting in mass displacement of
people, destruction of health infrastructure, and mass mortality by many easily preventable
causes. In the Eastern Mediterranean Region, greater political commitment, surveillance, and
operational capacity for national vaccination with the EPI package could result in a large number
of lives saved in a cost-effective manner. Strategic approaches are needed to reach high risk
populations and achieve polio eradication in these conflict-affected areas, as well as to prevent
excess morbidity and mortality.
One of the most important results from this review is its emphasis on the need for
improved documentation and evaluation of vaccination campaigns and vaccine preventable
disease in conflict-affected areas. More efforts are needed to document the impact of these
diseases in conflict areas, as well as evaluate effective intervention strategies, cost-effectiveness,
and cost-benefits of different vaccines. As the EPI considers adding even more vaccinations to
its basic package, it is important to understand the burden and necessity of their need in these
emergency situations.
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Appendix
Table A1. Search terms included in initial database search
!
!
Conflict-related terms
EMR terms
EPI Vaccine-related
terms
Refugees
Afghanistan
Poliomyelitis
refugee*.tw
Bahrain
Diphtheria
(internal* adj1
Dijbouti
Tuberculosis
displace*).tw
Egypt
Whooping cough
(displace* adj1
Iran
Measles
person*).tw
Iraq
Rubella
(conflict* adj1
Jordan
Tetanus
affected).tw
Kuwait
Haemophilus influenzae
(post* adj1
Lebanon
type b
conflict*).tw
Libya
Hepatitis B
War
Morocco
BCG vaccine
(wars or warfare or
Oman
Yellow fever
wartime or
Pakistan
(polio* or pertussis or
terrorism).tw
Qatar
HepB or HiB or DTP or
Saudi Arabia
OPV).tw
Somalia
Sudan
Syria
Tunisia
United Arab Emirates
Yemen

Child-related terms
Child
Infant
Child*.tw

Limited to English language.
Limited to 1974 - present (EPI was established in 1974).
!
Note: Terms separated by “OR” within columns; terms separated by “AND” between columns.
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Table A3. Description of Final Results
!
Author
(Year)

Title

Country of
Population's
Origin

Country
where study
took place

Disease
studied

Relevant findings

Original articles from database search

Assefa
(2001)

Malnutrition and mortality in
Kohistan district, Afghanistan,
April 2001

Afghanistan

Afghanistan

Measles

Boss
(1987)

Infant mortality and childhood
nutritional status among
Afghan refugees in Pakistan.

Afghanistan

Pakistan

Measles,
Tetanus

In the midst of a long civil conflict, the
crude mortality rate of children under 5
years was 5.6 per 10,000 per day, with
15.7% of deaths attributed to measles.
Polio vaccine coverage was low at 73.7%.
From 1984 to 1985, the percentages of
deaths <5 increased from 6 to 10% due to
tetanus and 8 to 24% due to measles.
However, overall percentage of death <5
improved from 22.5 to 18.8%.

Gessner
(1994)

Mortality rates, causes of death,
and health status among
displaced and resident
populations of Kabul,
Afghanistan

Measles

Highest mortality rates occurred in those
<5 years who had been at their current
location <10 months. Measles as cause of
death in both displaced and residents <5
years were respectively 18% and 10%.

Afghanistan

Afghanistan

AFP surveillance improved and the
number of children <5 vaccinated
increased due to NIDs and door-to-door
campaigns. However, southern Sudan still
has low OPV coverage of estimated 20%.
Despite coordinated SIAs, polio incidence
and the percentage of children <5 years
living in inaccessible areas increased from
2007 to 2008 in both countries. Security
access remained the top barrier to
vaccination access.
Afghanistan and Pakistan reported 31 and
118 WPV cases, respectively, attributing
most cases to conflict-affected regions and
border areas with security problems. OPV3
coverage was 83% and 44 SIAs occurred
in both countries combined.

MMWR
(2001)

Progress toward poliomyelitis
and dracunculiasis eradication Sudan, 1999-2000

Sudan

Sudan

Poliovirus

MMWR
(2009)

Progress towards interruption
of wild poliovirus transmission
- Afghanistan and Pakistan,
2008

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Poliovirus

MMWR
(2009)

Progress towards interruption
of wild poliovirus transmission
- worldwide, 2008

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Poliovirus

MMWR
(2010)

Progress towards interruption
of wild poliovirus transmission
- worldwide, 2009

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Poliovirus

MMWR
(2011)

Progress Toward Poliomyelitis
Eradication — Afghanistan and
Pakistan, January 2010September 2011

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Poliovirus

Afghanistan and Pakistan reported 38 and
89 WPV cases, respectively, with
difficulties continuing with accessing
children in insecure areas.
WPV incidence increased in both
Afghanistan and Pakistan during 20102011, with cases occurring mainly in
conflict-affected, inaccessible regions that
are insecure for vaccination teams.

Measles

Interruption of MCV services for 2 years
due to conflict led to a massive measles
outbreak, increasing from 145 to 1562
cases per million children <5 years.
Refugees also transported measles to

Kebede
(2012)

Measles - Horn of Africa,
2010-2011

Somalia

Somalia
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neighboring Ethiopia and Kenya.

MMWR
(2012)

Progress Toward Poliomyelitis
Eradication — Afghanistan and
Pakistan, January 2011-August
2012

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Poliovirus

MMWR
(2013)

Progress towards poliomyelitis
eradication in Pakistan, January
2012 - September 2013

Pakistan

Pakistan

Poliovirus

WPV incidence fell from 2011 to 2012,
but remains endemic in inaccessible areas
of both countries due to insecurity, where
hundreds of thousands of children are still
unvaccinated.
The number of WPV cases decreased from
54 to 52 from the same period a year prior.
OPV3 coverage was 89% with a large
range between provinces, due to security
limitations, vaccination bans, and targeted
attacks against polio workers.

Poliovirus

NIDs have been a partial success, with
significant discrepancies between rural and
urban and other sociodemographic factors.
EPI staff also faces difficulties such as
transport, lack of awareness, and security.

Measles

Due to breakdown in registration and
vaccination approaches, a measles
outbreak resulted in 17% of deaths, with
an overall <5 death rate of 1.8 per 10,000
person-days in the camp.

Hepatitis
B

Refugee mothers who were HBsAg
positive were much more likely to have an
HBV infected child (OR = 7.15). Children
<5 had a high prevalence of 5.9%.

Polonsky
(2013)

Coverage and causes of non
immunization in National
Immunization Days for polio; a
consumer and provider
perspective study in Peshawar.
High levels of mortality,
malnutrition, and measles,
among recently-displaced
Somali refugees in Dagahaley
camp, Dadaab refugee camp
complex, Kenya, 2011

Quddus
(2006)

Prevalence of hepatitis B
among Afghan refugees living
in Balochistan, Pakistan

Naeem
(2012)

Pakistan

Somalia

Afghanistan

Pakistan

Kenya

Pakistan

WER
(1999)

Progress toward poliomyelitis
eradication, Afghanistan 19941999

Afghanistan

Afghanistan

Poliovirus

WER
(2004)

Prevention of measles deaths in
Darfur, Sudan

Sudan

Sudan

Measles

Coverage of OPVs in children <5 was
estimated at 30% or lower for many
regions, with most vaccination occurring
during NIDs. Polio remained the leading
cause of disability in Afghanistan.
Measles outbreaks ensued after conflict
broke out with 711 cases and >10% case
fatality rate. Mass vaccination campaigns
had limited success; coverage was most
restricted in high conflict Western Darfur
and cases continued to occur.

Somalia

Diphtheria
, tetanus,
pertussis,
measles

Child Health Days have effectively
immunized 84% more infants with measles
vaccination than routine EPI services and
narrowed the gap between rural and urban
coverage.

Articles from Forward Search

Mirza
(2012)

Somalia: Supporting the Child
Survival Agenda When Routine
Health Service is Broken

Somalia
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MMWR
(2000)

Progress toward poliomyelitis
eradication - Eastern
Mediterranean Region, 1999 September 2000

Afghanistan,
Pakistan, Sudan

Afghanistan,
Pakistan,
Sudan

Poliovirus

Compared with the same1999 period,
confirmed cases in the EMR decreased by
50%. Pakistan accounts for 60% of cases.
Transmission interruption is expected in all
but 4 countries by the end of the year.

Poliovirus

Reduced to its lowest levels, WPV is still
endemic to Afghanistan and Pakistan due
to insecurity on the borders. OPV3
coverage was 83% in Pakistan and 77% in
Afghanistan with large regional variance.

MMWR
(2008)

Progress toward poliomyelitis
eradication - Afghanistan and
Pakistan, 2007

MMWR
(2008)

Progress toward interruption of
wild poliovirus transmission worldwide, January 2007 April 2008

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Poliovirus

MMWR
(2010)

Progress toward poliomyelitis
eradication - Afghanistan and
Pakistan, 2009

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Poliovirus

MMWR
(2011)

Progress toward interruption of
wild poliovirus transmission worldwide, January 2010 March 2011

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Poliovirus

MMWR
(2012)

Progress toward interruption of
wild poliovirus transmission worldwide, January 2011 March 2012

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Poliovirus

Moore
(1993)

Progress toward eradication of
polio - worldwide, January
2011- March 2013
Mortality rates in displaced and
resident populations of central
Somalia during 1992 famine

Toole
(1988)

An analysis of mortality trends
among refugee populations in
Somalia, Sudan, and Thailand

MMWR
(2013)

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Poliovirus

Somalia

Somalia

Measles

Somalia

Somalia, Sudan

Measles

WPV1 cases decreased substantially in
Afghanistan but not in Pakistan despite
little change in WPV3 cases; transmission
continues due to security and managerial
issues on the border.
Coordinated SIAs continued, but were
limited by security issues and population
displacement. Up to 20% of children were
inaccessible in both countries at certain
times of the year.
Afghanistan reported decreases in WPV
cases from 2009 to 2010, but Pakistan
reported significant increases despite
conducting many SIAs. Increased political
commitment and resources are needed.
Despite large reductions in worldwide
WPV incidence, substantial increases were
reported in WPV cases for Afghanistan
from 2010 to 2011, along with marginal
increases in Pakistan.
WPV cases decreased in both Afghanistan
and Pakistan with OPV3 coverage of 66%
and 75% respectively, with substantial in
country variability. However, attacks on
health workers threaten progress.
In displaced persons camps, <5 mortality
was estimated at 74% with primary causes
of death as diarrhea and measles.
Mortality rates for children <5 in Somali
and Sudanese refugee camps were
extremely high, up to 5 times higher than
non-refugee children in these countries. Up
to 60% of <5 deaths in some camps were
due to measles.

Table A4. Data Extraction from Final Results by Vaccine-Preventable Disease
Main EMR
Country of
Origin

Main
Country of
Study

Year

Reported #
of Cases

Total
Observations

Overall <5
Mortality

Diseasespecific
% of
death

Vaccination
Coverage of
Population

Author
(Pub
Year)

Type of
Study

Level of
Population

Adams 24
POLIOVIRUS

Afghanistan

Afghanistan

19941999

Afghanistan,
Pakistan,
Sudan

Afghanistan,
Pakistan,
Sudan

1999 Sept
2000

Sudan

Sudan

19992000

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Pakistan

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Jan
2007 Apr
2008

19 in SeptDec 1997; 59
in 1998; 43
in Jan-Aug
1999
63 in
Afghanistan;
324 in
Pakistan; 10
in Sudan in
1999
10 in 1999; 4
in 2000
17 in 2007
and 5 in JanApr 2008 in
Afghanistan;
32 in 2007
and 4 in JanApr 2008 in
Pakistan

2009

17 in
Afghanistan;
32 in
Pakistan
31 in
Afghanistan;
118 in
Pakistan
31 in
Afghanistan;
118 in
Pakistan
38 in
Afghanistan;
89 in
Pakistan

2009

38 in
Afghanistan;
89 in
Pakistan

2007

2008

2008

Pakistan

2010

Afghanistan,
Pakistan

Jan
2010 Mar
2011

Afghanistan,
Pakistan

Jan
2010 Sept
2011

N/A
25 in 2010
and 1 in JanMar 2011 in
Afghanistan;
144 in 2010
and 26 in
Jan-Mar
2011 in
Pakistan
25 in 2010
and 42 in
Jan-Sept
2011 in
Afghanistan;
144 in 2010

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

<30% (3
doses) in
1996; ~80%
(2 doses) in
1997
32% in
Afghanistan;
80% in
Pakistan, 77%
in Sudan
90% in 1999;
70% in 2000
(3 doses to <5
years)

WER
(1999)

Progress
update

Countrywide

MMWR
(2000)

Progress
update

EMR-wide

MMWR
(2001)

Progress
update

Countrywide

MMWR
(2008)

Progress
update

Worldwide

MMWR
(2008)

Progress
update

Countrywide

N/A

N/A

N/A

N/A

N/A

N/A

77% in
Afghanistan;
83% in
Pakistan (3
doses in <1
years)
77% in
Afghanistan;
83% in
Pakistan (3
doses in <1
years)

N/A

83% in both
(3 doses in <1
years)

MMWR
(2009)

Progress
update

Countrywide

N/A

83% in both
(3 doses in <1
years)

MMWR
(2009)

Progress
update

Worldwide

MMWR
(2010)

Progress
update

Worldwide

MMWR
(2010)

Progress
update

Countrywide

Naeem
(2012)

Crosssectional
household
survey

Province level

MMWR
(2011)

Progress
update

Worldwide

MMWR
(2011)

Progress
update

Countrywide

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

600 households
with children
<5

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

84% in EMR
(3 doses in <1
years)
85% in
Afghanistan;
81% in
Pakistan (3
doses in <1
years)

83.7% (3
doses)

86% in EMR
(3 doses in <1
years)
66% in
Afghanistan;
88% in
Pakistan (3
doses in <1
years)

Adams 25
and 120 in
Jan-Sept
2011 in
Pakistan

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Pakistan

Afghanistan,
Pakistan

Afghanistan,
Pakistan

Jan
2011 Aug
2012

80 in 2011
and 6 in JanMar 2012 in
Afghanistan;
198 in 2011
and 15 in
Jan-Mar
2012 in
Pakistan
80 in 2011
and 17 in
Jan-Aug
2012 in
Afghanistan;
198 in 2011
and 30 in
Jan-Aug
2012 in
Pakistan

Pakistan

Jan
2012 Sept
2013

Afghanistan,
Pakistan

Jan
2011 Mar
2013

Afghanistan,
Pakistan

Jan
2011 Mar
2012

N/A

N/A

N/A

N/A

MMWR
(2012)

Progress
update

Worldwide

66% in
Afghanistan;
75% in
Pakistan (3
doses in <1
years)

MMWR
(2012)

Progress
update

Countrywide

MMWR
(2013)

Progress
update

Countrywide

MMWR
(2013)

Progress
update

Worldwide

Systematic
household
survey

Refugee
camps

N/A

N/A

N/A

58 in 2012;
52 in JanSept 2013

N/A

N/A

N/A

37 in 2012 in
Afghanistan;
58 in 2012 in
Pakistan

N/A

N/A

N/A

10 in 1984;
27 in 1985

1512
households in
1984; 1566
households in
1985

225 per 1000
in 1984; 188
per 1000 in
1985

8% of
deaths in
1984; 24%
in 1985

N/A

Boss
(1987)

3 camps in
Somalia; 3
camps in Sudan

28 per 10,000
per day in
Somalia; 22.232.6 per
10,000 per
day in Sudan

60% in
Somalia;
most
common
cause in
Sudan

78% in
Somalia

Toole
(1988)

Cluster
household
survey

Refugee
camps

62 children in
Baidoa; 211 in
Bagoi

32 per 10,000
per day in
Baidoa; 10.4
per 10,000 per
day in Afgoi

25% in
Baidoa,
34% in
Afgoi

N/A

Moore
(1993)

Cluster
household
survey

Refugee
camps,
residents

89% (3 doses
in <1 years)
66% in
Afghanistan;
75% in
Pakistan (3
doses in <1
years)

MEASLES

Afghanistan

Somalia

Somalia

Pakistan

Somalia,
Sudan

Somalia

19841985

19801985

1992

N/A

33 in Baidoa;
39 in Afgoi

Adams 26

Afghanistan

Afghanistan

Sudan

Afghanistan

1993

312 displaced
families; 300
resident
families

18% in
displaced;
10% in
resident

74% of
displaced;
78% of
resident

N/A

Gessner
(1993)

Crosssectional
household
survey

City level

Assefa
(2001)

Cluster
household
survey

District level

WER
(2004)

Outbreak
investigation

Refugee
camps

Mirza
(2012)

Intervention
evaluation

Countrywide

Afghanistan

2001

14 deaths

763 children

5.9 per 10,000

23.70%

Sudan

MarchJune
2004

711 cases

N/A

N/A

10% Case
fatality rate

909,690 in
2009;
1,241,590 in
2010

180 per 1000
live births

N/A

77%
84% of
regions with
>50% routine
measles
coverage

N/A

N/A

N/A

46% in 2010
& 2011

Kebede
(2012)

Progress
update

Countrywide

6488 children
<5 years

1.8 per 10,000
person-days

83.90%

Polonsky
(2013)

Systematic
household
survey

Refugee camp

1%

Quddus
(2006)

Crosssectional
household
survey

Refugee
camps

Systematic
household
survey

Refugee
camps

Intervention
evaluation

Countrywide

Somalia

Somalia

20092010

Somalia

Somalia

20102011

Somalia

9 displaced
cases; 10
resident
cases

1.9 per 10,000
person-day
displaced; 1.1
per 10,000
person-day
resident

Kenya

2011

N/A
976 in 2010;
11,601 in
2011

619 cases

17%

HEPATITIS B

Afghanistan

Pakistan

2003

7

119

N/A

N/A

TETANUS (Vaccination is DPT: Diphtheria, Pertussis, Tetanus)

Afghanistan

Somalia

!

Pakistan

19841985

Somalia

20092010

8 in 1984; 11
in 1985

1512
households in
1984; 1566
households in
1985

225 per
1000 in
1984; 188
per 1000 in
1985

22% of
neonatal
deaths in
1984; 38%
in 1985

N/A

Boss
(1987)

N/A

36,460 in 2009;
53567 in 2010

180 per
1000 live
births

N/A

51% in 2009;
66% in 2010

Mirza
(2012)

